- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT05413733
Нейропсихологическая реабилитация через Интернет (IRENE)
Осуществимость и эффективность нейропсихологической реабилитации после приобретенной черепно-мозговой травмы с использованием Интернета
Helsinki University Hospital (HUS) has decided on a strategy to provide digital health care services for several medical specialties - a project called the Health Village (HealthVillage.fi). Within Health Village a specific digital My Path program, iRENE Digital Pathway, has been developed for web-based neuropsychological rehabilitation. iRENE Digital Pathway is a structured program for adults with an acquired brain injury (ABI), which utilizes psychoeducative information and self-evaluation questionnaires for attentional, memory and executive disorders with a feedback, and provides training for internal and external memory and other cognitive strategies. The current study will explore if web-based neuropsychological rehabilitation is a feasible and effective method for carrying out rehabilitation for adults with ABI.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
The IRENE study will explore the application, feasibility and effectiveness of web-based neuropsychological rehabilitation for working-aged patients with ABI during the first year of recovery. This study will adopt a 2-arm randomized controlled design with treatment-as-usual control.
The investigators will determine the feasibility and effectiveness of a web-based rehabilitation program for patients with ABI on their subjective memory difficulties, management of cognitive symptoms, self-efficacy, fatigue, mood, anxiety, quality of life and subjective working ability. The study will examine, if the method is accessible as well as if neurological patients are able and willing to use web-based rehabilitation. The potential health-economic benefits of the new rehabilitation program will be assessed with the duration of patients' sick leave after ABI and through the net benefit of neuropsychological rehabilitation resources.
A pilot randomized trial with 60 participants will be conducted to address the rate of recruitment of the participants, patient acceptability and adherence to study protocol, retention rates and feedback of the iRENE program as well as initial data on effectiveness of this new program. This pilot trial will use an unequal randomization 2:1 to maximize experiences in delivering the digital intervention to patients after ABI. The intervention group will participate in the iRENE Digital Pathway, a web-based rehabilitation program, that takes 2-3 months to complete. The control group attends treatment as usual, which includes necessary outpatient rehabilitation.
Outcome measures at baseline, post-intervention and 3-month follow-up after completing the intervention are gathered as self-assessments.
The participants are adult patients from neurological acute wards and outpatient clinics from HUS, Finland. Patients with ABI typically get referral to neuropsychological examination at the acute or the sub-acute phase of recovery. The examining clinical neuropsychologist offers a patient the possibility to get involved in the research. A neuropsychologist from the research group interviews voluntary patients at hospital or via telephone to confirm patient's interest and fulfillment of inclusion criteria.
Intervention group will go through a systematic web-based neuropsychological intervention program. Participants carry out the web-based intervention independently with their own digital appliance (computer, tablet or mobile phone) time and place of one's choice.
Control group attends the standard care of patients with ABI including all necessary outpatient rehabilitation visits. A possibility to attend to the iRENE Digital Pathway will be offered to control group participants after they have performed the 5-month assessment of the study.
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
-
Helsinki, Финляндия, FI-00029
- HUS Neurocenter, Helsinki University Hospital
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Acute neurological incident affecting cognition (stroke, encephalitis, traumatic brain injury, anoxia)
- Less than 6 months from occurrence of an acute neurological incident
- Mild to moderate cognitive deficits on a clinical neuropsychological assessment during inpatient or outpatient care after ABI
- Subjective cognitive symptoms following ABI
- Proficient in Finnish
- Must be able to use digital appliances
Exclusion Criteria:
- Not an acute neurological incident
- More than 6 months from an acute neurological incident
- Severe cognitive deficits on a clinical neuropsychological assessment during inpatient or outpatient care after ABI
- Not fluent in Finnish
- Not able to use digital appliances
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Другой
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Digital care pathway
Intervention group goes through a web-based neuropsychological intervention program. The program includes eight structured sessions regarding general neuropsychological symptoms after ABI - problems with fatigue, attention, executive functions and memory. A new session opens after the previous one is completed, and after a minimum of 3 days between the sessions. The intervention takes approximately 2 months depending on the progression pace of a patient. The eight sessions consist of psychoeducation, self-assessments, cognitive strategy training and feedback (automatic or given by a monitoring neuropsychologist). A neuropsychologist from HUS monitors patients' progression and provides personal feedback when needed. Participants can also be in contact with a monitoring neuropsychologist via message feature of the program. |
Sessions of the digital neuropsychological program:
Другие имена:
|
|
Активный компаратор: Care as usual
Control group attends the standard care of patients with ABI in HUS including all necessary outpatient rehabilitation visits. When available, neuropsychological rehabilitation typically takes 1-2 months among the study target group. |
The standard care of patients with ABI including all necessary outpatient rehabilitation visits. Neuropsychological visits may include a short period of psychoeducation with a clinical neuropsychologist. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change of Baseline Perceived Subjective Cognitive symptoms at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Everyday Memory Questionnaire - Revised; The minimum total score is 0 and the maximum score is 52; The higher total score represents more severe subjective cognitive symptoms |
Baseline, Month 2, and Month 5
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change of Baseline Perceived Use of Memory Aids at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Adaptation to Memory Difficulties Outcome Questionnaire; The questionnaire includes subscales assessing memory knowledge and emotional adjustment (15 questions), use of external memory aids (5 questions) and use of internal memory aids (5 questions); Each item will be scored on a 4-point scale 1-4; Each of the three parts of the questionnaire will be analyzed separately; A higher score would signify better adaptation. |
Baseline, Month 2, and Month 5
|
|
Change of Baseline Perceived Self-Efficacy at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the New General Self-Efficacy Scale; The New General Self-Efficacy Scale is an 8-item measure that assesses how much people believe they can achieve their goals, despite difficulties; The minimum total score is 1 and the maximum score is 5; The higher total score represents higher self-efficacy |
Baseline, Month 2, and Month 5
|
|
Change of Baseline Perceived Anxiety at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Patient-Reported Outcomes Measurement Information System (PROMIS): anxiety; The minimum total raw score is 8 and the maximum score is 40; The higher total score represents higher anxiety |
Baseline, Month 2, and Month 5
|
|
Change of Baseline Perceived Depression at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Patient-Reported Outcomes Measurement Information System (PROMIS): depression; The minimum total raw score is 8 and the maximum score is 40; The higher total score represents higher depression |
Baseline, Month 2, and Month 5
|
|
Change of Baseline Perceived Quality of life at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Euro-Qol (EQ-5D) Questionnaire; The minimum total raw score is 0 and the maximum score is 100; The higher score represents higher quality of life in terms of self-perceived health |
Baseline, Month 2, and Month 5
|
|
Change of Baseline Perceived Fatigue at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Fatigue Assessment Scale; The minimum total raw score is 10 and the maximum score is 50; The higher total score represents more severe fatigue |
Baseline, Month 2, and Month 5
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change of Baseline Perceived Working ability at 2 months and 5 months
Временное ограничение: Baseline, Month 2, and Month 5
|
Administration of the Work Ability Index; The minimum total score is 0 and the maximum score is 24; The higher total score represents better self-perceived working ability |
Baseline, Month 2, and Month 5
|
|
Length of sick leave of a patient
Временное ограничение: Month 5
|
Length of sick leave in days after acquired brain injury |
Month 5
|
|
Intervention feedback questionnaire
Временное ограничение: Month 2
|
Feedback of the neuropsychological rehabilitation period offered during the study; Participants give their evaluation in a 5-point likert scale; The higher total score represents more positive evaluation; % of patients with positive and negative evaluation will be reported |
Month 2
|
Соавторы и исследователи
Следователи
- Директор по исследованиям: Marja Hietanen, PhD, Helsinki University Central Hospital
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
- Нейровоспалительные заболевания
- Цереброваскулярные расстройства
- Заболевания головного мозга
- Заболевания центральной нервной системы
- Заболевания нервной системы
- Сосудистые заболевания
- Сердечно-сосудистые заболевания
- Раны и травмы
- Патологические процессы
- Кровотечение
- Ишемия головного мозга
- Признаки и симптомы, Респираторные
- Черепно-мозговая травма
- Травма, нервная система
- Инсульт
- Гипоксия, мозг
- Гипоксия
- Патологические состояния, признаки и симптомы
- Признаки и симптомы
- Ишемический приступ
- Повреждения головного мозга, травматические
- Травмы головного мозга
- Энцефалит
- Гипоксия-ишемия головного мозга
- Внутричерепные кровоизлияния
Другие идентификационные номера исследования
- TYH2022304
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .